$61.09
2.28%
Nasdaq, Jun 28, 10:04 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Target price 2024 - Analyst rating & recommendation

PROCEPT BioRobotics Classifications & Recommendation:

Buy
89%
Hold
11%

PROCEPT BioRobotics Target price

Target price $74.00
Course $61.09
Price potential
Number of estimates 7
7 Analysts have issued a price target PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics target price is $74.00. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend PROCEPT BioRobotics to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the PROCEPT BioRobotics share has an average upside potential 2025 of . Most analysts recommend the PROCEPT BioRobotics share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 136.19 213.73
81.56% 56.94%
EBITDA margin -77.36% -35.31%
24.05% 54.36%
Net margin -84.52% -46.71%
37.05% 44.74%

9 Analysts have issued a sales forecast PROCEPT BioRobotics 2024 . The average PROCEPT BioRobotics sales estimate is

$214m
unlock
. This is
36.72% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$215m 37.34%
unlock
, the lowest is
$213m 36.32%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $136m 81.56%
2024
$214m 56.94%
unlock
2025
$300m 40.58%
unlock
2026
$395m 31.54%
unlock
2027
$501m 26.64%
unlock
2028
$558m 11.49%
unlock

6 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2024. The average PROCEPT BioRobotics EBITDA estimate is

$-75.5m
unlock
. This is
27.73% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-69.6m 33.34%
unlock
, the lowest is
$-101m 3.47%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-105m 37.89%
2024
$-75.5m 28.37%
unlock
2025
$-48.0m 36.45%
unlock
2026
$-31.9m 33.55%
unlock

EBITDA margin

2023 -77.36% 24.05%
2024
-35.31% 54.36%
unlock
2025
-15.96% 54.80%
unlock
2026
-8.06% 49.50%
unlock

4 PROCEPT BioRobotics Analysts have issued a net profit forecast 2024. The average PROCEPT BioRobotics net profit estimate is

$-99.8m
unlock
. This is
8.37% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-99.2m 8.96%
unlock
, the lowest is
$-101m 7.55%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-115m 14.29%
2024
$-99.8m 13.28%
unlock
2025
$-79.3m 20.60%
unlock
2026
$-45.7m 42.30%
unlock
2027
$-21.1m 53.94%
unlock

Net margin

2023 -84.52% 37.05%
2024
-46.71% 44.74%
unlock
2025
-26.38% 43.52%
unlock
2026
-11.57% 56.14%
unlock
2027
-4.21% 63.61%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -2.24 -1.94
14.29% 13.39%
P/E ratio negative
EV/Sales 14.02

4 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics <a href=/blog/eps>EPS is

$-1.94
unlock
. This is
8.49% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-1.93 8.96%
unlock
, the lowest is
$-1.96 7.55%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-2.24 14.29%
2024
$-1.94 13.39%
unlock
2025
$-1.54 20.62%
unlock
2026
$-0.89 42.21%
unlock
2027
$-0.41 53.93%
unlock

P/E ratio

Current -28.79 64.14%
2024
-31.45 9.24%
unlock
2025
-39.60 25.91%
unlock
2026
-68.64 73.33%
unlock
2027
-149.00 117.07%
unlock

Based on analysts' sales estimates for 2024, the PROCEPT BioRobotics share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

14.02
unlock
and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of
14.70
unlock
.

This results in the following potential growth figures and future valuations:

EV/Sales

Current 19.17 17.10%
2024
14.02 26.85%
unlock
2025
9.98 28.87%
unlock
2026
7.58 23.98%
unlock
2027
5.99 21.04%
unlock
2028
5.37 10.31%
unlock

P/S ratio

Current 20.10 14.43%
2024
14.70 26.86%
unlock
2025
10.46 28.87%
unlock
2026
7.95 23.98%
unlock
2027
6.28 21.04%
unlock
2028
5.63 10.31%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now